25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

AVEFF (Avecho) Stock Analysis
Buy, Hold or Sell?

Let's analyze Avecho together

I guess you are interested in Avecho Biotechnology Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Avecho’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Avecho’s Price Targets

I'm going to help you getting a better view of Avecho Biotechnology Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Avecho Biotechnology Limited

I send you an email if I find something interesting about Avecho Biotechnology Limited.

1. Quick Overview

1.1. Quick analysis of Avecho (30 sec.)










1.2. What can you expect buying and holding a share of Avecho? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$0.00
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
-177.2%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0014 - $0.0014
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Avecho (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$-0.01 - $0.00
Total Value Per Share
$-0.01 - $0.00

2.2. Growth of Avecho (5 min.)




Is Avecho growing?

Current yearPrevious yearGrowGrow %
How rich?$2m$4m-$1.9m-95.1%

How much money is Avecho making?

Current yearPrevious yearGrowGrow %
Making money-$1.9m-$2.1m$198.8k10.1%
Net Profit Margin-241.3%-725.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Avecho (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#727 / 908

Most Revenue
#490 / 908

Most Profit
#277 / 908

Most Efficient
#601 / 908
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Avecho?

Welcome investor! Avecho's management wants to use your money to grow the business. In return you get a share of Avecho.

First you should know what it really means to hold a share of Avecho. And how you can make/lose money.

Speculation

The Price per Share of Avecho is $0.0014. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Avecho.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Avecho, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Avecho.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-44.5%0.00-44.5%0.00-49.0%0.00-42.6%0.00-91.3%
Usd Book Value Change Per Share0.00-44.3%0.00-44.3%0.0056.3%0.00-4.2%0.00-65.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-44.3%0.00-44.3%0.0056.3%0.00-4.2%0.00-65.2%
Usd Price Per Share0.00-0.00-0.00-0.00-0.00-
Price to Earnings Ratio-1.93--1.93--0.29--5.95--2.98-
Price-to-Total Gains Ratio-1.94--1.94-0.25--2.43--2.43-
Price to Book Ratio1.84-1.84-0.16-5.46-2.73-
Price-to-Total Gains Ratio-1.94--1.94-0.25--2.43--2.43-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0014
Number of shares714285
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (714285 shares)-442.91-42.44
Gains per Year (714285 shares)-1,771.65-169.78
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1772-17820-170-180
20-3543-35540-340-350
30-5315-53260-509-520
40-7087-70980-679-690
50-8858-88700-849-860
60-10630-106420-1019-1030
70-12402-124140-1188-1200
80-14173-141860-1358-1370
90-15945-159580-1528-1540
100-17716-177300-1698-1710

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.09.00.010.0%5.026.01.015.6%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.07.00.030.0%14.018.00.043.8%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%4.00.028.012.5%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.07.00.030.0%14.018.00.043.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Avecho Biotechnology Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.0010%0.001-179%0.000-90%-0.001+47%
Book Value Per Share--0.0010.0010%0.001-49%0.001-15%0.001-56%
Current Ratio--2.8122.8120%8.305-66%5.262-47%5.748-51%
Debt To Asset Ratio--0.3460.3460%0.129+169%0.219+58%0.180+92%
Debt To Equity Ratio--0.5280.5280%0.148+258%0.295+79%0.232+128%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--4212562.1984212562.1980%3518953.842+20%11594891.188-64%11594891.188-64%
Eps---0.001-0.0010%-0.001+10%-0.001-4%-0.001+105%
Ev To Ebitda Ratio---2.282-2.2820%-1.716-25%-7.595+233%-7.595+233%
Ev To Sales Ratio--5.1495.1490%11.752-56%28.228-82%28.228-82%
Free Cash Flow Per Share---0.001-0.0010%-0.001-20%-0.001-31%0.000-68%
Free Cash Flow To Equity Per Share---0.001-0.0010%0.001-177%0.000-94%0.000-803%
Gross Profit Margin--1.0001.0000%1.241-19%1.048-5%1.024-2%
Intrinsic Value_10Y_max---0.004--------
Intrinsic Value_10Y_min---0.012--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min---0.001--------
Intrinsic Value_3Y_max---0.001--------
Intrinsic Value_3Y_min---0.003--------
Intrinsic Value_5Y_max---0.002--------
Intrinsic Value_5Y_min---0.005--------
Market Cap4437019.955+14%3803159.9623803159.9620%633859.994+500%10395303.895-63%5197651.948-27%
Net Profit Margin---2.413-2.4130%-7.257+201%-4.553+89%-5.327+121%
Operating Margin---2.369-2.3690%-7.225+205%-4.531+91%-4.099+73%
Operating Ratio--1.0001.0000%10.314-90%6.289-84%6.313-84%
Pb Ratio2.146+14%1.8401.8400%0.157+1070%5.460-66%2.730-33%
Pe Ratio-2.248-17%-1.927-1.9270%-0.292-85%-5.953+209%-2.977+55%
Price Per Share0.001+14%0.0010.0010%0.000+500%0.003-63%0.002-27%
Price To Free Cash Flow Ratio-1.768-17%-1.516-1.5160%-0.315-79%-8.311+448%-4.155+174%
Price To Total Gains Ratio-2.258-17%-1.935-1.9350%0.254-863%-2.429+25%-2.429+25%
Quick Ratio--2.7022.7020%7.831-65%4.283-37%5.043-46%
Return On Assets---0.625-0.6250%-0.470-25%-0.646+3%-0.689+10%
Return On Equity---0.955-0.9550%-0.539-44%-0.841-12%-0.857-10%
Total Gains Per Share---0.001-0.0010%0.001-179%0.000-90%-0.001+47%
Usd Book Value--2067455.3372067455.3370%4032663.971-49%2436051.334-15%4735960.702-56%
Usd Book Value Change Per Share---0.001-0.0010%0.001-179%0.000-90%-0.001+47%
Usd Book Value Per Share--0.0010.0010%0.001-49%0.001-15%0.001-56%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--4212562.1984212562.1980%3518953.842+20%11594891.188-64%11594891.188-64%
Usd Eps---0.001-0.0010%-0.001+10%-0.001-4%-0.001+105%
Usd Free Cash Flow---2509420.391-2509420.3910%-2010685.547-20%-1719453.351-31%-797647.715-68%
Usd Free Cash Flow Per Share---0.001-0.0010%-0.001-20%-0.001-31%0.000-68%
Usd Free Cash Flow To Equity Per Share---0.001-0.0010%0.001-177%0.000-94%0.000-803%
Usd Market Cap4437019.955+14%3803159.9623803159.9620%633859.994+500%10395303.895-63%5197651.948-27%
Usd Price Per Share0.001+14%0.0010.0010%0.000+500%0.003-63%0.002-27%
Usd Profit---1974070.950-1974070.9500%-2172937.520+10%-1890826.000-4%-4051297.346+105%
Usd Revenue--818147.513818147.5130%299426.297+173%525045.227+56%921302.389-11%
Usd Total Gains Per Share---0.001-0.0010%0.001-179%0.000-90%-0.001+47%
 EOD+5 -3MRQTTM+0 -0YOY+14 -245Y+9 -2910Y+15 -23

3.3 Fundamental Score

Let's check the fundamental score of Avecho Biotechnology Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.248
Price to Book Ratio (EOD)Between0-12.146
Net Profit Margin (MRQ)Greater than0-2.413
Operating Margin (MRQ)Greater than0-2.369
Quick Ratio (MRQ)Greater than12.702
Current Ratio (MRQ)Greater than12.812
Debt to Asset Ratio (MRQ)Less than10.346
Debt to Equity Ratio (MRQ)Less than10.528
Return on Equity (MRQ)Greater than0.15-0.955
Return on Assets (MRQ)Greater than0.05-0.625
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Avecho Biotechnology Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5099.331
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.001
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.001
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Avecho Biotechnology Limited

Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery. Its human health portfolio covers delivery of pharmaceutical products for pain and dermatology applications through gels, injectables, and patches. In addition, the company develops pharmaceutical products; oral, topical, and edible pharmaceutical cannabinoid products, including a cannabidiol TPM soft-gel capsule in Phase III clinical trial for the treatment of insomnia; and non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.

Fundamental data was last updated by Penke on 2025-04-04 05:23:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Avecho earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Avecho to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -241.3%Β means thatΒ $-2.41 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Avecho Biotechnology Limited:

  • The MRQ is -241.3%. The company is making a huge loss. -2
  • The TTM is -241.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-241.3%TTM-241.3%0.0%
TTM-241.3%YOY-725.7%+484.4%
TTM-241.3%5Y-455.3%+214.1%
5Y-455.3%10Y-532.7%+77.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-241.3%-99.7%-141.6%
TTM-241.3%-188.1%-53.2%
YOY-725.7%-199.6%-526.1%
5Y-455.3%-357.6%-97.7%
10Y-532.7%-488.5%-44.2%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Avecho is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Avecho to theΒ Biotechnology industry mean.
  • -62.5% Return on Assets means thatΒ Avecho generatedΒ $-0.62 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Avecho Biotechnology Limited:

  • The MRQ is -62.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -62.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-62.5%TTM-62.5%0.0%
TTM-62.5%YOY-47.0%-15.5%
TTM-62.5%5Y-64.6%+2.1%
5Y-64.6%10Y-68.9%+4.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-62.5%-12.3%-50.2%
TTM-62.5%-12.2%-50.3%
YOY-47.0%-12.0%-35.0%
5Y-64.6%-13.4%-51.2%
10Y-68.9%-15.3%-53.6%
4.3.1.3. Return on Equity

Shows how efficient Avecho is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Avecho to theΒ Biotechnology industry mean.
  • -95.5% Return on Equity means Avecho generated $-0.95Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Avecho Biotechnology Limited:

  • The MRQ is -95.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -95.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-95.5%TTM-95.5%0.0%
TTM-95.5%YOY-53.9%-41.6%
TTM-95.5%5Y-84.1%-11.4%
5Y-84.1%10Y-85.7%+1.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-95.5%-16.1%-79.4%
TTM-95.5%-16.2%-79.3%
YOY-53.9%-15.8%-38.1%
5Y-84.1%-19.5%-64.6%
10Y-85.7%-21.7%-64.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Avecho Biotechnology Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Avecho is operatingΒ .

  • Measures how much profit Avecho makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Avecho to theΒ Biotechnology industry mean.
  • An Operating Margin of -236.9%Β means the company generated $-2.37 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Avecho Biotechnology Limited:

  • The MRQ is -236.9%. The company is operating very inefficient. -2
  • The TTM is -236.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-236.9%TTM-236.9%0.0%
TTM-236.9%YOY-722.5%+485.6%
TTM-236.9%5Y-453.1%+216.3%
5Y-453.1%10Y-409.9%-43.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-236.9%-188.3%-48.6%
TTM-236.9%-291.0%+54.1%
YOY-722.5%-214.8%-507.7%
5Y-453.1%-368.2%-84.9%
10Y-409.9%-471.9%+62.0%
4.3.2.2. Operating Ratio

Measures how efficient Avecho is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 1.00 means that the operating costs are $1.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Avecho Biotechnology Limited:

  • The MRQ is 1.000. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.000. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.000TTM1.0000.000
TTM1.000YOY10.314-9.314
TTM1.0005Y6.289-5.289
5Y6.28910Y6.313-0.024
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0002.233-1.233
TTM1.0003.152-2.152
YOY10.3143.084+7.230
5Y6.2895.091+1.198
10Y6.3136.520-0.207
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Avecho Biotechnology Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Avecho is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 2.81Β means the company has $2.81 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Avecho Biotechnology Limited:

  • The MRQ is 2.812. The company is able to pay all its short-term debts. +1
  • The TTM is 2.812. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.812TTM2.8120.000
TTM2.812YOY8.305-5.493
TTM2.8125Y5.262-2.450
5Y5.26210Y5.748-0.485
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8123.616-0.804
TTM2.8123.893-1.081
YOY8.3054.280+4.025
5Y5.2625.791-0.529
10Y5.7486.182-0.434
4.4.3.2. Quick Ratio

Measures if Avecho is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Avecho to theΒ Biotechnology industry mean.
  • A Quick Ratio of 2.70Β means the company can pay off $2.70 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Avecho Biotechnology Limited:

  • The MRQ is 2.702. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.702. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.702TTM2.7020.000
TTM2.702YOY7.831-5.129
TTM2.7025Y4.283-1.582
5Y4.28310Y5.043-0.759
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7022.920-0.218
TTM2.7023.417-0.715
YOY7.8314.170+3.661
5Y4.2835.727-1.444
10Y5.0436.469-1.426
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Avecho Biotechnology Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of AvechoΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Avecho to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.35Β means that Avecho assets areΒ financed with 34.6% credit (debt) and the remaining percentage (100% - 34.6%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Avecho Biotechnology Limited:

  • The MRQ is 0.346. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.346. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.346TTM0.3460.000
TTM0.346YOY0.129+0.217
TTM0.3465Y0.219+0.127
5Y0.21910Y0.180+0.039
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3460.344+0.002
TTM0.3460.344+0.002
YOY0.1290.332-0.203
5Y0.2190.359-0.140
10Y0.1800.384-0.204
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Avecho is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Avecho to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 52.8% means that company has $0.53 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Avecho Biotechnology Limited:

  • The MRQ is 0.528. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.528. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.528TTM0.5280.000
TTM0.528YOY0.148+0.381
TTM0.5285Y0.295+0.233
5Y0.29510Y0.232+0.063
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5280.407+0.121
TTM0.5280.427+0.101
YOY0.1480.402-0.254
5Y0.2950.448-0.153
10Y0.2320.493-0.261
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Avecho generates.

  • Above 15 is considered overpriced butΒ always compareΒ Avecho to theΒ Biotechnology industry mean.
  • A PE ratio of -1.93 means the investor is paying $-1.93Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Avecho Biotechnology Limited:

  • The EOD is -2.248. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.927. Based on the earnings, the company is expensive. -2
  • The TTM is -1.927. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.248MRQ-1.927-0.321
MRQ-1.927TTM-1.9270.000
TTM-1.927YOY-0.292-1.635
TTM-1.9275Y-5.953+4.027
5Y-5.95310Y-2.977-2.977
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.248-1.809-0.439
MRQ-1.927-2.564+0.637
TTM-1.927-3.191+1.264
YOY-0.292-3.323+3.031
5Y-5.953-6.424+0.471
10Y-2.977-7.149+4.172
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Avecho Biotechnology Limited:

  • The EOD is -1.768. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.516. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.516. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.768MRQ-1.516-0.253
MRQ-1.516TTM-1.5160.000
TTM-1.516YOY-0.315-1.200
TTM-1.5165Y-8.311+6.795
5Y-8.31110Y-4.155-4.155
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.768-2.461+0.693
MRQ-1.516-3.566+2.050
TTM-1.516-3.951+2.435
YOY-0.315-4.482+4.167
5Y-8.311-8.693+0.382
10Y-4.155-9.796+5.641
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Avecho is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 1.84 means the investor is paying $1.84Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Avecho Biotechnology Limited:

  • The EOD is 2.146. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.840. Based on the equity, the company is underpriced. +1
  • The TTM is 1.840. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.146MRQ1.840+0.307
MRQ1.840TTM1.8400.000
TTM1.840YOY0.157+1.682
TTM1.8405Y5.460-3.620
5Y5.46010Y2.730+2.730
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.1461.676+0.470
MRQ1.8402.283-0.443
TTM1.8402.457-0.617
YOY0.1572.507-2.350
5Y5.4603.773+1.687
10Y2.7304.321-1.591
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-12-312021-12-312022-12-312023-12-312024-12-31
Total Other Income Expense Net 488229717-261456273729-2,703-1,974



6.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets4,997
Total Liabilities1,727
Total Stockholder Equity3,270
 As reported
Total Liabilities 1,727
Total Stockholder Equity+ 3,270
Total Assets = 4,997

Assets

Total Assets4,997
Total Current Assets4,810
Long-term Assets187
Total Current Assets
Cash And Cash Equivalents 2,375
Net Receivables 2,246
Inventory 137
Other Current Assets 52
Total Current Assets  (as reported)4,810
Total Current Assets  (calculated)4,810
+/-0
Long-term Assets
Property Plant Equipment 171
Long-term Assets Other 16
Long-term Assets  (as reported)187
Long-term Assets  (calculated)187
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,710
Long-term Liabilities17
Total Stockholder Equity3,270
Total Current Liabilities
Short-term Debt 1,062
Short Long Term Debt 978
Accounts payable 61
Other Current Liabilities 588
Total Current Liabilities  (as reported)1,710
Total Current Liabilities  (calculated)2,689
+/- 978
Long-term Liabilities
Long-term Liabilities  (as reported)17
Long-term Liabilities  (calculated)0
+/- 17
Total Stockholder Equity
Common Stock244,606
Retained Earnings -269,392
Accumulated Other Comprehensive Income 28,056
Total Stockholder Equity (as reported)3,270
Total Stockholder Equity (calculated)3,270
+/-0
Other
Capital Stock244,606
Cash and Short Term Investments 2,375
Common Stock Shares Outstanding 3,169,297
Liabilities and Stockholders Equity 4,997
Net Debt -1,298
Net Invested Capital 4,248
Net Working Capital 3,100
Property Plant and Equipment Gross 171
Short Long Term Debt Total 1,077



6.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-311995-12-311994-12-311993-12-31
> Total Assets 
11,875
11,193
34,482
33,011
5,522
1,620
5,096
20,860
18,397
14,839
29,408
114,034
171,072
173,494
171,521
69,189
67,364
53,768
76,577
64,121
42,958
50,901
30,744
13,354
8,240
4,802
5,315
3,355
5,246
3,346
7,319
4,997
4,9977,3193,3465,2463,3555,3154,8028,24013,35430,74450,90142,95864,12176,57753,76867,36469,189171,521173,494171,072114,03429,40814,83918,39720,8605,0961,6205,52233,01134,48211,19311,875
   > Total Current Assets 
11,875
1,749
111
372
17
281
2,277
4,665
3,559
2,250
2,424
7,934
14,648
16,026
12,371
13,510
11,547
3,724
30,759
23,117
14,155
27,056
17,956
10,183
5,802
3,247
4,278
2,691
4,808
2,851
7,004
4,810
4,8107,0042,8514,8082,6914,2783,2475,80210,18317,95627,05614,15523,11730,7593,72411,54713,51012,37116,02614,6487,9342,4242,2503,5594,6652,277281173721111,74911,875
       Cash And Cash Equivalents 
147
296
81
183
1
153
2,236
4,232
3,284
2,196
2,312
7,222
13,189
14,425
10,715
12,896
10,868
2,740
27,196
16,912
8,823
20,679
12,395
6,092
2,899
2,111
3,211
1,873
3,265
1,468
5,504
2,375
2,3755,5041,4683,2651,8733,2112,1112,8996,09212,39520,6798,82316,91227,1962,74010,86812,89610,71514,42513,1897,2222,3122,1963,2844,2322,236153118381296147
       Short-term Investments 
10,038
0
0
0
0
0
29
400
240
0
14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000140240400290000010,038
       Net Receivables 
1,674
1,453
30
189
13
128
12
33
36
31
66
660
1,003
1,498
1,577
232
292
305
2,376
4,993
4,421
5,213
4,724
3,607
2,395
677
755
37
40
746
1,100
2,246
2,2461,10074640377556772,3953,6074,7245,2134,4214,9932,3763052922321,5771,4981,003660663136331212813189301,4531,674
       Other Current Assets 
16
0
0
189
3
0
0
0
0
22
32
45
390
50
64
170
329
157
223
358
212
562
542
247
218
359
163
681
1,307
235
303
52
523032351,3076811633592182475425622123582231573291706450390453222000031890016
   > Long-term Assets 
0
9,444
34,371
32,639
5,505
1,339
2,819
16,195
14,838
12,589
26,985
106,099
156,424
157,468
159,150
55,679
55,817
50,044
45,818
41,004
28,803
23,845
12,788
3,171
2,437
1,555
1,037
664
438
494
316
187
1873164944386641,0371,5552,4373,17112,78823,84528,80341,00445,81850,04455,81755,679159,150157,468156,424106,09926,98512,58914,83816,1952,8191,3395,50532,63934,3719,4440
       Property Plant Equipment 
0
0
0
0
0
0
19
167
143
120
96
280
611
1,023
1,902
3,617
3,755
2,767
2,563
2,370
2,196
814
519
385
251
160
180
233
336
468
316
171
1713164683362331801602513855198142,1962,3702,5632,7673,7553,6171,9021,0236112809612014316719000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
34,261
34,261
34,261
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000034,26134,26134,261000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
105,820
121,552
122,184
122,987
52,062
52,062
45,577
43,255
38,634
26,607
23,031
12,269
2,786
2,186
1,395
857
431
102
26
0
0
00261024318571,3952,1862,78612,26923,03126,60738,63443,25545,57752,06252,062122,987122,184121,552105,82000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000
> Total Liabilities 
1,459
380
5,579
5,836
73
33
72
185
56
30
25
811
38,935
38,020
37,759
17,636
17,375
14,761
3,631
1,509
2,187
1,873
1,816
1,707
1,836
902
556
700
709
921
942
1,727
1,7279429217097005569021,8361,7071,8161,8732,1871,5093,63114,76117,37517,63637,75938,02038,9358112530561857233735,8365,5793801,459
   > Total Current Liabilities 
763
92
2,168
2,961
73
33
72
185
56
30
25
811
38,935
1,102
841
1,508
1,247
931
3,602
1,453
2,120
1,778
1,781
1,663
1,714
873
545
604
696
746
843
1,710
1,7108437466966045458731,7141,6631,7811,7782,1201,4533,6029311,2471,5088411,10238,9358112530561857233732,9612,16892763
       Short-term Debt 
0
0
1
0
0
0
0
0
39
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
89
73
80
71
-81
1,062
1,062-8171807389000000000000000003900000100
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
978
9780000000000000000000000000000000
       Accounts payable 
0
0
0
2,951
0
0
8
185
58
30
25
342
52
270
50
1,032
989
548
1,997
512
311
582
409
571
1,239
572
97
110
75
191
95
61
619519175110975721,2395714095823115121,9975489891,03250270523422530581858002,951000
       Other Current Liabilities 
0
92
2,167
10
0
0
64
0
-41
0
0
468
38,883
832
791
476
258
383
1,605
941
1,809
1,196
1,372
1,092
366
301
359
420
540
483
513
588
5885134835404203593013661,0921,3721,1961,8099411,60538325847679183238,88346800-4106400102,167920
   > Long-term Liabilities 
696
288
3,411
2,875
0
0
0
0
0
0
0
0
0
36,918
36,918
16,128
16,128
13,830
29
56
67
95
35
44
123
30
11
97
14
175
98
17
17981751497113012344359567562913,83016,12816,12836,91836,9180000000002,8753,411288696
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30
4
3
0
0
0
0
000034300000000000000000000000000
> Total Stockholder Equity
10,416
10,813
28,903
27,175
5,449
1,587
5,024
20,675
18,341
14,808
29,383
113,223
132,184
135,474
133,762
51,553
49,989
39,007
72,946
62,612
40,771
49,028
28,928
11,647
6,403
3,900
4,759
2,654
4,537
2,425
6,378
3,270
3,2706,3782,4254,5372,6544,7593,9006,40311,64728,92849,02840,77162,61272,94639,00749,98951,553133,762135,474132,184113,22329,38314,80818,34120,6755,0241,5875,44927,17528,90310,81310,416
   Common Stock
10,000
11,228
11,926
12,780
13,167
14,174
17,107
33,932
33,933
34,750
39,701
134,731
145,306
154,608
161,544
170,316
176,905
176,905
209,546
209,861
209,895
228,100
228,100
228,100
231,274
232,632
232,632
232,778
237,602
237,529
244,606
244,606
244,606244,606237,529237,602232,778232,632232,632231,274228,100228,100228,100209,895209,861209,546176,905176,905170,316161,544154,608145,306134,73139,70134,75033,93333,93217,10714,17413,16712,78011,92611,22810,000
   Retained Earnings 
416
-570
-5,143
-7,974
-8,725
-12,586
-12,083
-13,257
-18,622
-22,971
-25,633
-25,751
-41,028
-47,154
-56,042
-147,248
-155,749
-167,024
-165,918
-176,973
-199,038
-209,243
-229,363
-246,677
-255,222
-259,149
-256,026
-258,661
-262,067
-264,104
-267,440
-269,392
-269,392-267,440-264,104-262,067-258,661-256,026-259,149-255,222-246,677-229,363-209,243-199,038-176,973-165,918-167,024-155,749-147,248-56,042-47,154-41,028-25,751-25,633-22,971-18,622-13,257-12,083-12,586-8,725-7,974-5,143-570416
   Capital Surplus 00000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
-1
0
0
47
0
0
0
0
0
0
0
0
0
0
0
0
30,416
28,153
28,537
29,002
29,000
0
0
0029,00029,00228,53728,15330,4160000000000004700-1000000000



6.4. Balance Sheets

Currency in AUD. All numbers in thousands.




6.5. Cash Flows

Currency in AUD. All numbers in thousands.




6.6. Income Statements

Currency in AUD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,294
Cost of Revenue-461
Gross Profit833833
 
Operating Income (+$)
Gross Profit833
Operating Expense-833
Operating Income-4,7970
 
Operating Expense (+$)
Research Development-
Selling General Administrative1,301
Selling And Marketing Expenses-
Operating Expense8331,301
 
Net Interest Income (+$)
Interest Income62
Interest Expense-57
Other Finance Cost-0
Net Interest Income4
 
Pretax Income (+$)
Operating Income-4,797
Net Interest Income4
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-3,122-1,675
EBIT - interestExpense = -3,122
-3,122
-3,065
Interest Expense57
Earnings Before Interest and Taxes (EBIT)-3,065-3,065
Earnings Before Interest and Taxes (EBITDA)-2,920
 
After tax Income (+$)
Income Before Tax-3,122
Tax Provision-0
Net Income From Continuing Ops-3,122-3,122
Net Income-3,122
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses1,294
Total Other Income/Expenses Net-3,122-4
 

Technical Analysis of Avecho
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Avecho. The general trend of Avecho is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Avecho's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Avecho Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Avecho Biotechnology Limited.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0014 < 0.0014 < 0.0014.

The bearish price targets are: 0.0014 > 0.0014 > 0.0014.

Know someone who trades $AVEFF? Share this with them.πŸ‘‡

Avecho Biotechnology Limited Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Avecho Biotechnology Limited. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Avecho Biotechnology Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Avecho Biotechnology Limited. The current macd is 0.00000.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Avecho price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Avecho. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Avecho price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Avecho Biotechnology Limited Daily Moving Average Convergence/Divergence (MACD) ChartAvecho Biotechnology Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Avecho Biotechnology Limited. The current adx is 98.03.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Avecho shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Avecho Biotechnology Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Avecho Biotechnology Limited. The current sar is 0.00129522.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Avecho Biotechnology Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Avecho Biotechnology Limited. The current rsi is 99.33. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -1/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
Avecho Biotechnology Limited Daily Relative Strength Index (RSI) ChartAvecho Biotechnology Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Avecho Biotechnology Limited. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Avecho price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Avecho Biotechnology Limited Daily Stochastic Oscillator ChartAvecho Biotechnology Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Avecho Biotechnology Limited. The current cci is 66.67.

Avecho Biotechnology Limited Daily Commodity Channel Index (CCI) ChartAvecho Biotechnology Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Avecho Biotechnology Limited. The current cmo is 99.98.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Avecho Biotechnology Limited Daily Chande Momentum Oscillator (CMO) ChartAvecho Biotechnology Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Avecho Biotechnology Limited. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Avecho Biotechnology Limited Daily Williams %R ChartAvecho Biotechnology Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Avecho Biotechnology Limited.

Avecho Biotechnology Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Avecho Biotechnology Limited. The current atr is 0.0000.

Avecho Biotechnology Limited Daily Average True Range (ATR) ChartAvecho Biotechnology Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Avecho Biotechnology Limited. The current obv is -24,180.

Avecho Biotechnology Limited Daily On-Balance Volume (OBV) ChartAvecho Biotechnology Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Avecho Biotechnology Limited. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Avecho Biotechnology Limited Daily Money Flow Index (MFI) ChartAvecho Biotechnology Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Avecho Biotechnology Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Avecho Biotechnology Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Avecho Biotechnology Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5099.331
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.001
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.001
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Avecho with someone you think should read this too:
  • Are you bullish or bearish on Avecho? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Avecho? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Avecho Biotechnology Limited

I send you an email if I find something interesting about Avecho Biotechnology Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Avecho Biotechnology Limited.

Receive notifications about Avecho Biotechnology Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.